Related Experiment Video
Updated: Dec 10, 2025

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry
Published on: July 13, 2019
Fifty Years of JC Polyomavirus: A Brief Overview and Remaining Questions
Abigail L Atkinson1, Walter J Atwood1
1Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI 02912, USA.
Abstract:
In the fifty years since the discovery of JC polyomavirus (JCPyV), the body of research representing our collective knowledge on this virus has grown substantially. As the causative agent of progressive multifocal leukoencephalopathy (PML), an often fatal central nervous system disease, JCPyV remains enigmatic in its ability to live a dual lifestyle. In most individuals, JCPyV reproduces benignly in renal tissues, but in a subset of immunocompromised individuals, JCPyV undergoes rearrangement and begins lytic infection of the central nervous system, subsequently becoming highly debilitating-and in many cases, deadly. Understanding the mechanisms allowing this process to occur is vital to the development of new and more effective diagnosis and treatment options for those at risk of developing PML. Here, we discuss the current state of affairs with regards to JCPyV and PML; first summarizing the history of PML as a disease and then discussing current treatment options and the viral biology of JCPyV as we understand it. We highlight the foundational research published in recent years on PML and JCPyV and attempt to outline which next steps are most necessary to reduce the disease burden of PML in populations at risk.
Insights
JC polyomavirus (JCPyV) causes progressive multifocal leukoencephalopathy (PML) in immunocompromised individuals. Understanding JCPyV
Area of Science:
- Virology
- Neuroscience
- Immunology
Background:
- JC polyomavirus (JCPyV) is a human polyomavirus.
- Progressive multifocal leukoencephalopathy (PML) is a rare, fatal demyelinating disease of the central nervous system.
- JCPyV is the causative agent of PML.
Observation:
- JCPyV establishes a persistent, usually asymptomatic infection in the kidneys of most individuals.
- In immunocompromised individuals, JCPyV can reactivate, undergo genetic rearrangement, and infect oligodendrocytes in the central nervous system.
- This lytic infection leads to progressive demyelination and severe neurological deficits.
Findings:
- The dual lifestyle of JCPyV, residing benignly in renal tissues versus causing lytic CNS infection, remains incompletely understood.
- Recent research has shed light on JCPyV's viral biology and the pathogenesis of PML.
- Key mechanisms enabling JCPyV reactivation and neuroinvasion in specific hosts are areas of active investigation.
Implications:
- A deeper understanding of JCPyV pathogenesis is crucial for developing effective diagnostic and therapeutic strategies for PML.
- Identifying individuals at risk and intervening early could significantly reduce PML-associated morbidity and mortality.
- Further research into JCPyV-host interactions may reveal novel targets for antiviral therapies and immune-based interventions.
Related Concept Videos
Retrovirus Life Cycles
Introduction to Virus
Mechanisms of Retrovirus-induced Cancers
Retroviruses
What are Viruses?
Polytene Chromosomes

